Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Berberine in the Treatment of Metabolic Syndrome : an Open Label Clinical Study in Female Schizophrenia Patients

NCT03251716 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.

NCT NCT03251716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03251716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Berberine in the Treatment of Metabolic Syndrome : an Open Label Clinical Study in Female Schizophrenia Patients
Lead sponsor
Tianjin Anding Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2015
Completion date
December 30, 2017
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female, metabolic syndrome, schizophrenia